6 ms·
Ecstasy for PTSD: Not Ready for Prime Time
- teebot 14y ago"Placebo controlled: 12 patients got the active drug, 8 got an inactive placebo Exit poll: 95% correctly guessed which group they were assigned to." No kidding
- loceng 14y agoWho structured this study? They're doing it wrong ...
- wahnfrieden 14y agoThey're doing it right, this is just piss-poor journalism. See Alex3917's reply.
- jpdoctor 14y ago> Exit poll: 95% correctly guessed which group they were assigned to. [ie, knew they had taken XTC or not] This pins the WTF meter. 1 out of the 20 could not figure it out? In related info: The controlled studies for viagra were a bit comical.
- Nursie 14y agoYou just know one of them was sat there saying 'I am so high right now!' but hadn't been given anything. Suggestion is a powerful thing to some folks.
- radley 14y agoOr simply "I'm feeling better". Not everyone has experienced highness. Contact-high is also possible.
- pchivers 14y agoFrom what I understand this 95% figure is not that far off from what is obtained in anti-depressant trials, but somehow the poor blinding of anti-depressant trials is almost never mentioned as a serious methodological problem. This is discussed in more detail in Irving Kirsch's The Emperor's New Drugs.
- Nursie 14y agoThe issue here has to be that it's hard to mask MDMA - people are going to know they're on something even at therapeutic (rather than recreational) doses, are they not? Is that really poor blinding? Antidepressants tend to be long lasting and slow acting (AFAICT) which MDMA is not.
- pchivers 14y agoTrue, antidepressants are much slower acting than MDMA, but you're still looking at 80-90% of people in antidepressant trials who can correctly guess which group they're in (due to side effects such as dry mouth, sleep problems, sexual dysfunction, etc.). Regarding the issue of whether or not it is poor blinding, I guess it is a bit like the tree falling in the forest but nobody is around to hear it: if you conduct a placebo-controlled study, but all the participants can correctly guess which group they're in, is it really a placebo-controlled study?
- Nursie 14y agoLikely a rhetorical question on your part there, but it is an interesting conundrum. Because the drug works directly on the brain and folks emotions, and because those effects are directly bound up with the therapeutic area under study, I can't help thinking a placebo would be really hard to do well here. Any other phenethylamine that subjectively mimics MDMA is going to be messing with the same systems. I guess (as may have been suggested elsewhere) you could use a non-seratonergic stimulant of some sort to give people the feeling that they are on something, and rely on them not being able to tell what it is. You'd need to screen for anyone that had any recreational experience though.
- Nursie 14y agoI wonder why the focus is on MDMA? IMHO it's entirely possible that the same or better effects could be found from a related substance like MBDB, and some (again like MBDB) seem to be less toxic than MDMA. The page also mentions that the reputation of MDMA preceded it and may have had an impact on the study. Using a less well known substance may have tackled this.
- loceng 14y agoMDMA is what's popular in the recreation scene and so will draw attention over others; Even Madonna not-so-subtly promotes it through her "MDNA" album and tour name - though most are none-the-wiser.
- davidtanner 14y agoWrong. It's because MDMA was successfully used in the 70s for psychotherapy before it was scheduled. Between uncontrolled clinical reports, the self-reports of users, and modern controlled studied there is a wealth of evidence that MDMA can be used for psychotherapy with excellent results.
- bitwize 14y agoOh snap, I thought she was punning on a different chemical (to wit: deoxyribonucleic acid)...
- Alex3917 14y agoOnce again Science Based Medicine shows that it's just a propaganda outlet for big pharma: "The study is characterized as blinded; but the blinding didn’t work, since 95% of subjects were able to tell which group they were in." As the researchers themselves say, the purpose of the study was to test their methodology before doing larger trials, including whether or not their blinding protocols were effective. They are going to be using active placebos for phase III, which are much more effective for blinding. In fact many of the other studies they've done already use active placebos, either a lower dose of MDMA or else something like methylphenidate. The authors address this in the actual study and explain that they now have FDA approval to use a three-arm protocol in the future, but SBM is pretending that this a methodological problem they found themselves. "There is only a pilot study with scanty, preliminary, unconfirmed evidence." There have been at least a dozen studies looking at MDMA as a treatment for PTSD, but again the author is pretending that this is the only one. "Experiments using illegal drugs are always problematic, because researchers tend to be advocates for legalization and may be biased by their emotional investment." Most of the MDMA studies use a triple blind methodology which is far more rigorous than the methodology that big pharma uses. What this means is that not only are the patients and the people administering the drug blinded (or will be going into phase III trials), but also the people analyzing the data were not the ones administering the drugs so they have no idea who was in each group. Also, these are multi-site trials going on in various countries around the world, including ones where the legal status and cultural baggage surrounding MDMA is wildly different in both researchers and the general population. "The patients in the placebo group improved, too; so a large part of the benefit could be attributed to the psychotherapy." As one would expect. However, they still had PTSD whereas the people who got the MDMA didn't. Additionally, studies have shown that the MDMA group continues to improve in the months and years after therapy much more than the control group. "The addition of MDMA to psychotherapy might prove helpful in refractory cases of PTSD, but the preliminary results of this one small pilot study will need to be confirmed by larger studies in combat veterans before the treatment can recommended to patients." Agreed. Except for that again there have been many studies of MDMA as a treatment for PTSD, not just this one. "Unfortunately, the history of medicine is full of equally promising treatments that didn’t pan out. Probably the most typical course is this: a strongly positive pilot study is followed by larger studies with weaker positive results, then by studies with equivocal or negative results, then reports of serious side effects or other problems, and eventually by rejection of the treatment. I sincerely hope this one will prove an exception to that course, for the sake of suffering veterans with few remaining options. But I am not optimistic." The reason why this has happened consistently in medicine is because the studies are being funded by for profit companies and they are using extremely biased methodology to make their drugs look much better than they actually are. Whereas MAPS is a non-profit, and their methodology is designed to be as neutral as possible. The research may well still not pan out as trial sizes increase and patients are more effectively double blinded, but there is definitely reason for optimism based on the results so far. For what it's worth, there are numerous videos online where you can watch the researchers (and MAPS) talking about these studies: http://www.maps.org/videos/source/video3.html http://www.maps.org/videos/source/video3.html (This video is with Michael Mithoefer, one of the researchers behind this study.) http://vimeo.com/32062578 http://vimeo.com/32062578 (Talk given by MAPS about the roadmap for getting MDMA approved.) There are several more videos online here about both the mechanisms of action, the pharmacology, and the results of other trials: http://www.maps.org/media/videos/ http://www.maps.org/media/videos/
- bitteralmond 14y agoI'm always skeptical of using this stuff for PTSD since the comedown is so harsh. I would suspect that the period of serotonin depletion could actually be just as bad for PTSD as the MDMA "high" could be good. Though I guess it's also important to note that taking MDMA with your therapist in a quiet room is nothing like taking it in a loud, dark room with your friends.
- Nursie 14y agoIs the come-down bad though, if the doses given are sub-recreational and are followed by proper amounts of sleep? Not to mention if you can ensure you're getting the right thing and not some dodgy multiply-substituted cathinone or piperazine!
- mietek 14y agoDo you mean the comedown from pure MDMA?
- darkarmani 14y agoI don't think the comedown is harsh for non-recreational doses. Also, you only do the therapy sessions during the high, so the serotonin depletion shouldn't matter much. There is very little evidence that MDMA at therapeutic doses causes any more damage than all of the other legal prescription drugs like prozac.
- 001sky 14y agoWith a name like "Science-Based Medicine" it just has to be true </sarcasm>
- dmix 14y agoWarning: people on PTSD are most likely on anti-depressants such as SSRI's and MAOI's which have interactions with MDMA, potentially causing serotonin syndrome. http://en.wikipedia.org/wiki/Serotonin_syndrome http://en.wikipedia.org/wiki/Serotonin_syndrome It can take weeks to a month of widthdrawl from SSRI to prevent interactions.
- veb 14y agoNot necessarily. PTSD is a lot more complex than simple depression. Doctors will try and fix the depression, but then something else will "arrive" and wreck havoc. Whether that's anxiety, flashbacks or something else that's not "always there" when you're simply "just" depressed. It's nearly impossible to treat PTSD as a whole with conventional medicine.
- dmix 14y agoYep, I'm not saying SSRI's are more effective, but theres a good possibility that someone with PTSD is already on it and self-medication could be dangerous. > The most commonly prescribed class of medications for PTSD (and the one approved by the U.S. Food and Drug Administration) are the selective serotonin reuptake inhibitor (SSRI) antidepressants. http://psychcentral.com/lib/2006/an-overview-of-treatment-of-ptsd/ http://psychcentral.com/lib/2006/an-overview-of-treatment-of...
- tokenadult 14y agoThanks for the several comments that came in while I was busy with a work project. The author of the submitted commentary article, Harriet Hall, M.D., is a retired military physician. It is reasonable to assume that she has a personal bias toward finding effective treatments for military post-traumatic stress syndrome (PTSD), and perhaps also a personal bias toward finding effective treatments for PTSD after rape. Contrary to several comments posted while I was busy, the edited group blog Science-Based Medicine is about applying the methods and settled factual conclusions of science to the existing practice of "evidence-based medicine." As the group of authors put it, "Science-Based Medicine is dedicated to evaluating medical treatments and products of interest to the public in a scientific light, and promoting the highest standards and traditions of science in health care." http://www.sciencebasedmedicine.org/index.php/about-science-based-medicine/ http://www.sciencebasedmedicine.org/index.php/about-science-... There have been a variety of posts on the site over the years critical of large pharmaceutical companies, and there have been a variety of posts critical of various aspects of current medical practice. The tenor of the site is that everyone involved in treating human patients and guarding their health needs to be truth-seeking, considering prior probabilities and scientific fact when evaluating new treatments. The authors are not a propaganda outlet for any industry, and they have no financial conflicts of interest on the issues they write about. Dr. Hall correctly points out that "Prolonged exposure therapy is a widely recognized therapy for PTSD. The rationale for using MDMA is to suppress anxiety and allow patients to talk about their traumatic experiences without feeling excessive fear and hyperarousal." Any effort to find a new treatment for PTSD, whether a prescribed drug or a new form of talk therapy, will have to be evaluated against what is already available to treat that tough disorder. Any reader of Hacker News who hasn't seen the link below already should definitely check out LISP hacker (and Google director of research) Peter Norvig's article "Warning Signs in Experimental Design and Interpretation," http://norvig.com/experiment-design.html http://norvig.com/experiment-design.html which is a great checklist of what to look for in a report of a new research finding. Dr. Hall knows how to evaluate research reports in this framework, and she urges that people (like her) who hope that more effective treatments for PTSD are developed proceed carefully so that the new treatments are truly safe and effective.